Biotech10 months ago
BioNTech Signs an Agreement with Wuxi for $20 Million to Develop New Antibodies
A week ago, BioNTech presented its billing forecasts for 2024, with the aim of reaching €3 billion. The figure represents a significant decrease in value compared...